Conferences
#ESHBMFS2026

ESH-EBMT-EHA-IPIG 4th Translational Research Conference
Bone Marrow Failure and Leukaemia Predisposition Syndromes

#ESHBMFS2026
Translational
November 6-8, 2026
-
Vienna, Austria

Chairs: Carmem Bonfim, Tim Brümmendorf, Antonio Risitano, Sharon Savage
‍
Scientific Committee: Beatrice Drexler, Carlo Dufour, Morag Griffin, Régis Peffault de Latour

ESH-EBMT-EHA-IPIG 4th Translational Research Conference
Bone Marrow Failure and Leukaemia Predisposition Syndromes

Our Chairs

Carmem Bonfim
Tim Brümmendorf
Antonio Risitano
Sharon Savage

Information

‍

November 6-8, 2026 – Vienna, Austria

Chairpersons: Carmem Bonfim, Tim Brümmendorf, Antonio Risitano, Sharon Savage

Scientific Committee: Beatrice Drexler, Carlo Dufour, Morag Griffin, Régis Peffault de Latour


With the support of the Severe Aplastic Anaemia Working Party of the EBMT, the EHA SWG on Granulocyte and Bone Marrow Failures and the International PNH Interest Group


#ESHBMFS2026

‍

ABOUT THE CONFERENCE:

On behalf of the European School of Haematology, the Severe Aplastic Anaemia Working Party of the EBMT, the EHA SWG on Granulocyte and Bone Marrow Failures and the International PNH Interest Group, we are pleased to announce and to invite you to the ESH-EBMT-EHA-IPIG 4th Translational Research Conference: Bone Marrow Failure and Leukaemia Predisposition Syndromes.

This conference will be of particular value for clinicians and non- clinical scientists, M.D. and Ph.D. of all ages interested in the biology, pathophysiology, diagnosis and treatment of bone marrow failure syndromes (BMFS) and leukaemia predisposition syndromes. We will not only discuss the standard of care in acquired but also inherited BMFS occurring in adult and pediatric patients, but particularly focus on new underlying principles and evolving new treatment strategies. In good tradition of ESH, we will put special effort on low threshold exchange between young scientists and experts in the field, as well as between clinicians and basic scientists. Meet-the-experts workshop as well as poster walks will allow to highlight topics of special attention and to enable further in-depth exchange. Our dedicated faculty will secure the highest standard of both clinical, translational and basic research.

‍

Main Scientific Topics:

•  Stem cell biology
•  Inherited predisposition to leukaemia
•  Constitutional marrow failure
•  Constitutional marrow failure: telomere biology diseases and others…
•  Clonal Haematopoiesis
•  Complement & PNH
•  Pathophysiology of aplastic anaemia
•  New therapies in haematology disorders
•  Treatment of aplastic anaemia
•  Unmet medical needs in BMFS

‍

Learning Objectives:

•  Improve understanding of the stem cell biology of BMF, from genotoxic stress, inflammaging to failure
•  Acquire knowledge of recent advances in Fanconi Anaemia, Ribosome diseases and telomere biology disorder
•  Gain insight into novel therapeutics of Paroxysmal Nocturnal Haemoglobinuria and idiopathic Aplastic Anaemia, including knowledge of complement cascade, the current developmental status of various targeted drugs and of novel antibody-based and small molecules based immunotherapeutic approaches, and their promise for future clinical application
•  Acquire an overview of emerging approaches and new challenges such as genetic editing of haemopoietic stem cells, single cell RNA sequencing in haemopoiesis and genetic predisposition for myeloid malignancies.

‍

The Programme will include:

•  Plenary Sessions
•  Panel Discussions
•  Poster Walks
•  Meet the Expert Sessions
•  Brief Oral Communications
•  Ample time for in-depth discussions and networking

‍

This conference is a Face to Face meeting. No virtual attendance is scheduled.

Programme

Read the scientific programme!

CLICK HERE

Abstract submission

‍

CALL FOR ABSTRACTS IS CLOSED

Abstracts are eligible to be selected for a brief oral communication or a poster presentation.

‍

Guidelines for your abstract submission:

1. Your abstract should be structured (e.g. Objectives, Methods, Results, Conclusions)
2. Maximum number of words: 500
3. Your abstract will be submitted to the peer review procedure.

‍

We accept “encore” abstract.

Presentation of data at this conference will not jeopardize acceptance of the same at the following ASH congress.

Venue

‍

Austria Trend Hotel Savoyen

Rennweg 16
1030 Vienna
AUSTRIA

‍

How to get there:

•  From Vienna International Airport: Train ÖBB S7 to Wien Rennweg station - Travel time: 25 minutes

•  From Vienna City Centre: Tramway line 71 to Rennweg  - Travel time: 10 minutes

‍

Accommodation

‍

Austria Trend Hotel Savoyen

Rennweg 16, 1030 Vienna, Austria


Reservation deadline: October 5th, 2026.
The number of reserved rooms is limited, please book as early as possible after conference registration.

‍

Warning!

We have detected scam activity of a company trying to sell accommodation services to the speakers of our conferences. Apparently, they have been collecting information on the speakers from the lists that are made public on our websites.
Please make sure you book your accommodation either via the link(s) provided by ESH on this page, or directly with the hotel or renown booking services platform.

IPIG Scholarships

‍

This Call for Applications is made thanks to
‍

Eligibility criteria:

•  Must be the first or senior author and the presenter of the abstract submitted for this conference.
•  Submitted abstract must be clearly focused on PNH, dealing with any biological or clinical aspect of its pleiotropic presentation

‍

The scholarship will cover:

•  Registration fee in the 4th ESH-EBMT-EHA-IPIG Translational Research Conference on Bone Marrow Failure and Leukaemia Predisposition Syndromes (which includes conference materials, the welcome get-together, coffee breaks and luncheons during the conference).
•  Three nights of accommodations.
•  Airfare stipend — $500 for EU-based applicants / $1,500 for applicants outside the EU.

Please note: Scholarships recipients are responsible for making their own travel arrangements and should submit for reimbursement per the stipend guidelines above

‍

Call for applications is closed.

ESH Scholarship Fund

‍

This Call for Applications is made thanks to a funding support from:

This call for applications is open exclusively to physicians in training, without any geographical restrictions.

‍

The scholarship will cover:

•  Your registration fee
•  A travel grant to a maximum of 500 €


Deadline for applications: September 7th, 2026

Application form to be sent to: Changyi Jiang

‍

The ESH Scholarship Fund is a multi-sponsored project designed to support access to new biological and clinical data in the context of lifelong learning in Haematology.
‍
ESH independently ensures all scientific peer review and selection procedures.
ESH is also independently responsible for all administrative aspects of the Fund.

‍

Call for applications is closed.

Contact

‍

For more information on this conference, please contact Changyi Jiang

ON-DEMAND CONTENT AVAILABLE (Exclusively to participants until February 10, 2027)
CLICK HERE

Corporate partners

With the support of*:

‍

‍

__wf_reserved_inherit

‍Major Conference Partner‍
‍*******

‍

‍

__wf_reserved_inherit

‍Level 1 Conference Partner‍
‍*******

‍

‍

__wf_reserved_inherit

Supporting Conference Partner‍
‍*******

*ESH conference programmes are developed in strict scientific independence
with no input from corporate sponsors.

‍

Advancing haematology through international leading-edge disease- focused conferences.

Explore a portfolio of leading-edge scientific, translational research and clinically oriented meetings, designed to foster scientific exchange, practical insight, education and collaboration across clinical and research fields.
Explore all conferences